Michael J. Miille

Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services.

Part of Dow Silicones Corp., Quanterra, Inc. provides lab analysis. Quanterra was acquired by Dow Silicones Corp. from IT Group, Inc. on June 26, 1998 for $5.75 million.

Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA.

Part of Applied Biosystems, Inc., Zoogen, Inc. provides genetic analysis services to owners of domestic and exotic animals. The company is based in Davis, CA. Zoogen was acquired by Applera Corp. on April 05, 1996.

AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC.